Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. - Wikidata - thesis-toulmin - TriplyDB

Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.

Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.

http://www.wikidata.org/entity/Q34441673

about

Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Soluble Urokinase Receptor and Chronic Kidney Disease.Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus Nanomedicines for renal disease: current status and future applications The next generation of therapeutics for chronic kidney disease Macro- and microvascular endothelial dysfunction in diabetes.An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update.Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.Patent highlights August-September 2016.

P2860

Q33741426-E604FC09-F09E-4DA8-A201-978B7512AA78 Q36429637-B23ABB9D-BA54-4E1C-8F00-9EEB0EAF460A Q37587674-00C276BC-9B23-4B46-B9EA-112CBFD8EA65 Q38802375-4A515D9E-448E-424C-99B8-997B8728ED9D Q38845590-0D8E51C7-9537-49AF-8B40-31DDF9D27B68 Q39065434-E1AA0202-0269-4641-8266-45E470534B62 Q42285693-4E5A8F3A-8FC7-4269-8FBB-B4E9FBB5AD45 Q47243282-B9162FA8-278A-48FC-A572-DEB4A793DA33 Q51055209-CC7309D6-6AD5-4CED-9F62-73C4228C8D76 Q52573827-F56F666A-7E13-44B0-8D8E-3B1E886EDAC9 Q54076993-F8733143-6EBE-4117-A47E-14D3D4351822

P2860

Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.

http://www.wikidata.org/entity/Q34441673

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@ast

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@en

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@nl

type

label

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@ast

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@en

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@nl

prefLabel

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@ast

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@en

Blocking αVβ3 integrin ligand ...... albuminuria in diabetic rats.

@nl

P1433

Q34441673-6BD79CB9-D3FD-41FD-BB0D-4DE96311D4E3

P1476

Q34441673-54D12F3D-4B85-4DE2-95C7-6F24DDA247DB

P2093

Q34441673-177B2495-1A4E-4C13-8EC4-AD1860720B6B

Q34441673-38BBEE35-5237-4D95-87CF-87976BE3C681

Q34441673-7AA9D228-B62E-46E0-B158-17695A448CB6

Q34441673-8786A3CE-EE76-4FCB-A6C6-7893780661D5

Q34441673-D9990811-BBDB-43E9-BD9F-4976F89C1C59

P2860

Q34441673-098F1AAF-AD65-4A31-9EAE-3FD609DAD0BA

Q34441673-0EB4D449-BCC4-40E2-B96E-937C4139B611

Q34441673-1A4B7843-0A66-43D1-ABD6-4C7FCB8C0EE1

Q34441673-1B5F6C24-368C-4908-85E0-562F6F787866

Q34441673-222C13CF-0D35-40F4-8D35-7E0210C48AE0

Q34441673-24DDD78A-7E22-4C88-BDB9-F2AEC6D6A8C3

Q34441673-253733A6-F23C-497A-BD4A-79CC43575B0A

Q34441673-346274A1-CBD0-4665-AFCE-0A444E229374

Q34441673-3AEAAF13-AD63-4482-953E-F4F936E8019A

Q34441673-3DD59C04-1178-4A1B-9379-84915E0A165F

P304

Q34441673-5FB3FC4B-93C1-41C3-912B-A71EFA1F1580

P31

Q34441673-8A5D4C96-8600-48CF-B3E3-119450BA0BDC

P356

Q34441673-5AAB8217-F8B9-4FE2-9F1F-5E12D764C638

P478

Q34441673-344958B0-03A1-4948-A547-B664C3527273

P50

Q34441673-07727329-2B9F-453A-9336-C954AFFC48DB

P577

Q34441673-360D28C0-5B34-490B-ABC2-8EEFC9001A6B

P5875

Q34441673-E653029B-6442-4076-A640-BB0A6B1D195C

P698

Q34441673-C95901A4-7401-435F-9A6F-63B2A7CD8F26

P932

Q34441673-EB3606F4-1EF4-4F9A-811D-0A0EE956927E

P356

P1433

Journal of Diabetes Research

P1476

Blocking αVβ3 integrin ligand ...... f albuminuria in diabetic rats

@en

P2093

Christine Wai

http://www.w3.org/2001/XMLSchema#string

David Clemmons

http://www.w3.org/2001/XMLSchema#string

Katherine Gollahon

http://www.w3.org/2001/XMLSchema#string

Laura A Maile

http://www.w3.org/2001/XMLSchema#string

Walker Busby

http://www.w3.org/2001/XMLSchema#string

P2860

Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study

Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit

Potential new therapeutic agents for diabetic kidney disease.

Mouse models of diabetic nephropathy.

Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

Blocking ligand occupancy of the αVβ3 integrin inhibits the development of nephropathy in diabetic pigs

Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.

Urinary markers of glomerular injury in diabetic nephropathy

P304

421827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/421827

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268232131

http://www.w3.org/2001/XMLSchema#string

P698

25389530

http://www.w3.org/2001/XMLSchema#string

P932

4217341

http://www.w3.org/2001/XMLSchema#string